Orgenesis Inc (NASDAQ:ORGS) CEO Vered Caplan updates Proactive on ways in which the group is aiming to combat the coronavirus. Caplan spoke to Proactive about its BioShield Program, which is designed to use neutralizing human antibodies as a possible rapid defense and to potentially mitigate the spread of viruses such as the coronavirus that causes the COVID-19 disease.
Orgenesis Inc outlines ways in which the group is aiming to combat the coronavirus
Quick facts: Orgenesis
Price: 5.36 USD
Market Cap: $118.43 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Orgenesis named herein, including the promotion by the Company of Orgenesis in any Content on the Site, the Company receives from said issuer...FOR OUR FULL DISCLAIMER CLICK HERE